Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 11.44M | $ -41.45M | -362.47% |
3/31/2025 | $ 15.12M | $ -43.13M | -285.31% |
12/31/2024 | $ 7.35M | $ -53.36M | -725.74% |
9/30/2024 | $ 38.13M | $ -27.76M | -72.8% |
6/30/2024 | $ 44.08M | $ -26.31M | -59.69% |
3/31/2024 | $ 44.87M | $ -23.6M | -52.59% |
12/31/2023 | $ 49.38M | $ -16.78M | -33.98% |
9/30/2023 | $ 56.43M | $ -10.47M | -18.56% |
6/30/2023 | $ 59.26M | $ -4.37M | -7.37% |
3/31/2023 | $ 59.94M | $ 6.52M | 10.88% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for PROPHASE LABS INC is calculated as follows: Net Inc. Cmn. [ $ -1.61M ] / Equity [ $ 10.76M ]
(=) ROE [ -15% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.13K |
---|---|
min | -66.24% |
max | 73.25% |
average | 1.63% |
median | 6.53% |
std | 22.52% |